Pharmaceutical compound testing

Gentiss offers advanced epidermal and full-thickness skin models tailored to meet the specific needs of the pharmaceutical industry. Our models replicate the structural and functional complexity of human skin, making them ideal for drug efficacy, safety, and mechanistic studies. We can also customize our models to your specific research needs. Whether it’s testing new topical formulations or understanding their effect on epidermal or dermal morphogenesis, our skin models provide reliable, reproducible data. Additionally, we offer in-depth biological analyses, such as cytokine profiling, to assess inflammatory responses, gene expression studies to explore molecular pathways, and protein analyses to evaluate drug-target interactions and pathway modulation. Gentiss human skin models streamline your development processes, reducing time-to-market while ensuring regulatory compliance and product safety.

Readouts

MTT assay

Cell viability analysis through the assessment of metabolic activity

MTT assay

Cell viability analysis through the assessment of metabolic activity

Histology

Assessment of skin morphology and presence of proteins

Histology

Assessment of skin morphology and presence of proteins

Cytokine profile

Detection of inflammatory response markers

Cytokine profile

Detection of inflammatory response markers

LDH assay

Evaluation of cytotoxicity via enzyme activity

LDH assay

Evaluation of cytotoxicity via enzyme activity

Gene expression

Analysis of cellular response through qPCR

Gene expression

Analysis of cellular response through qPCR

Barrier function

Measurement of skin permeability

Barrier function

Measurement of skin permeability

Disease modelling

Our disease-specific human skin models offer a powerful platform for researchers and institutions to study the mechanisms behind various skin conditions. From chronic inflammatory diseases like eczema and psoriasis, to rare genetic disorders, our models accurately replicate characteristics of these conditions. We support preclinical research, drug screening, and biomarker discovery, offering valuable insights into disease progression and treatment responses. Our disease modelling services accelerate the discovery of novel therapeutics tailored to specific skin diseases.

Disease model variants

Eczema

LEM and FTM models with specific cytokine cocktail to induce eczema phenotype

Eczema

LEM and FTM models with specific cytokine cocktail to induce eczema phenotype

Psoriasis

LEM and FTM models with specific cytokine cocktail to induce psoriatic phenotype

Psoriasis

LEM and FTM models with specific cytokine cocktail to induce psoriatic phenotype

Fibrosis

FTM and FDM models with relevant cells and addition of growth factor cocktail to induce fibrotic phenotype

Fibrosis

FTM and FDM models with relevant cells and addition of growth factor cocktail to induce fibrotic phenotype

Melanoma

Various cell lines are used to mimic melanoma

Melanoma

Various cell lines are used to mimic melanoma

Basal cell carcinoma

Various cell lines and primary cancer cells are used to mimic BCC

Basal cell carcinoma

Various cell lines and primary cancer cells are used to mimic BCC

Cutaneous lymphoma

Various cell lines and primary cancer cells are used to mimic cutaneous lymphoma

Cutaneous lymphoma

Various cell lines and primary cancer cells are used to mimic cutaneous lymphoma

Cancer modelling

We provide highly specialized skin cancer models such as squamous cell carcinoma (SCC), melanoma, and vulvar SCC, that enable the exploration of cancer development and treatment efficacy. These cancer models closely mimic the tumor microenvironment, as they harbour cancer associated fibroblasts, supporting studies on epidermal morphogenesis, epithelial to mesenchymal transition, tumor invasion, and drug resistance. Whether you are conducting fundamental cancer research or working on new therapeutic approaches, our skin cancer modelling helps bridge the preclinical gap between in vitro experiments and clinical trials. Our comprehensive cancer models support screening, personalized medicine development, and novel drug validation.

Cancer model variants

Squamous cell carcinoma

Various cell lines and primary cancer cells are used to mimic SCC

Squamous cell carcinoma

Various cell lines and primary cancer cells are used to mimic SCC

Melanoma

Various cell lines are used to mimic melanoma

Melanoma

Various cell lines are used to mimic melanoma

Basal cell carcinoma

Various cell lines and primary cancer cells are used to mimic BCC

Basal cell carcinoma

Various cell lines and primary cancer cells are used to mimic BCC

Cutaneous lymphoma

Various cell lines and primary cancer cells are used to mimic cutaneous lymphoma

Cutaneous lymphoma

Various cell lines and primary cancer cells are used to mimic cutaneous lymphoma

Vulvar cancer

Various cell lines are used to mimic vulvar cancer

Vulvar cancer

Various cell lines are used to mimic vulvar cancer

Head and neck cancer

Various cell lines are used to mimic head and neck cancer

Head and neck cancer

Various cell lines are used to mimic head and neck cancer

Wound healing

Our wound healing models are designed to support investigation into both superficial and deep wound conditions. These models closely mimic the human skin’s response to injury, providing a platform to test new wound care treatments, biomaterials, and tissue regeneration therapies. For applications such as innovative dressings, scar treatments, and wound healing studies, our full-thickness skin models deliver reliable data that can translate directly into clinical applications.

Wound heading model variants

Superficial wounding

Models with wound applied to the epidermis only

Superficial wounding

Models with wound applied to the epidermis only

Full-thickness wounds

Models with wound applied to the epidermis and dermis

Full-thickness wounds

Models with wound applied to the epidermis and dermis

Chronic wounds

Diabetic foot ulcer models

Chronic wounds

Diabetic foot ulcer models

Infection modelling

Gentiss offers sophisticated infection models that simulate bacterial infections in skin. These models enable researchers to study pathogen-host interactions, infection dynamics, and immune responses in skin models that have superficial or deep wounds. They are ideal for testing antimicrobial agents and novel therapies targeting skin infections. Our infection models provide a realistic environment for evaluating the effectiveness of treatments against a wide range of skin pathogens, helping researchers and companies develop safer, more effective therapies.

Infection model variants

Viral infection

Inoculation with virus of interest

Viral infection

Inoculation with virus of interest

Bacterial infection

Inoculation with bacteria of interest

Bacterial infection

Inoculation with bacteria of interest

Dosage studies

Our human skin models support dosage studies for topical and transdermal products, ensuring accurate and efficient evaluation of drug delivery and concentration for safe and effective treatments.

Skin homeostasis

We perform studies on skin homeostasis, allowing investigations on epidermal and dermal morphogenesis, by examining basal membrane formation, differentiation processes, cell proliferation, cytokine profiling, gene expression and barrier integrity in response to various treatments and environmental factors.

Barrier composition

Our models are designed to analyze the effects of compounds on skin barrier function, enabling precise studies of how active ingredients, environmental factors, and formulations impact barrier integrity by examining ceramide composition, trans-epidermal water loss, barrier related proteins, and lipid processing enzymes on gene and protein levels.

Request a quote

Contact us to find out more about how we can help with pharmaceutical product testing

Others also looked at